Enanta Pharmaceuticals Inc. has announced a new immunology program and updated progress in its immunology pipeline. The company’s new program is focused on developing oral MRGPRX2 inhibitors for type ...
Scientists have presented a new approach to cancer treatment using mast cells, which are immune cells known for their ability ...
The map was developed by using single-cell RNA sequencing to analyze 1.4 million plasma and immune cells in bone marrow from over 300 patients.
Continuing Phase 3 Enabling Activities, Including Discussions with U.S. Food & Drug Administration (FDA) Following Positive ...
(n=6) enrolled in the BEACON study achieved a complete response at 12 weeks with a mean UAS7 reduction of 31 points ...
Thomas Wiggans appointed Executive Chairperson Jasper to host an investor webinar on January 8th at 8:00am ET to present updated data from the BEACON study in CSU and the open-label extension study ...
As of Thursday, January 08, Jasper Therapeutics, Inc.’s JSPR share price has dipped by 14.63%, which has investors questioning if this is right time to buy.
Jasper Therapeutics Inc (NASDAQ:JSPR) stock rose 4.9% in after-hours trading Wednesday following the announcement of key ...
Jasper Therapeutics, Inc. (Nasdaq: JSPR) (Jasper or the Company), a clinical stage biotechnology company focused on ...
Even in whispered summer gyms, the chatter is back. Rienk Mast is moving closer to taking his place among the Big Ten's upper tier. Nebraska's multi-talented forward missed the entire 2024–25 season ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback